Findings of a Study With a Novel Antibody-Drug Conjugate in Ovarian Cancer

October 24, 2016
Jasgit Sachdev, MD

Jasgit Sachdev, MD, clinical associate professor at Translational Genomics Research Institute, discusses a recent study of novel antibody-drug conjugate targeting protein tyrosine kinase 7 (PTK7) in ovarian cancer.